fashion -WSS

fashion

author：knowledge 2025-09-30 16:25:48 - browse：58

George Yancopoulos on the 2024 Breakthrough Summit East stage. — George Yancopoulos on the 2024 Breakthrough Summit East stage STAT

George Yancopoulos is in touch with his teenage self.

After 35 years as head scientist at Regeneron Pharmaceuticals, Yancopoulos has led the development of 12 approved medicines, turning a once-fledgling company into the $100 billion global drugmaker it is today. And you can trace a straight line back to the childhood fascination with science he fostered growing up in Woodside, Queens.

“My high school science project was about regenerating neurons, and ‘Regeneron’ is a contraction of ‘regenerating neurons,’” Yancopoulos said at the STAT Summit East on Thursday. “In some ways I’m still working on my high school science project.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Some top drug companies are starting to take action on climate

WSS

FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

The Karikó problem: Lessons for funding basic research

The United States is paying nearly triple for new Covid vaccines

6 solutions to address cancer drug shortages and others

New oral drug delivery patch is modeled after octopus tentacles

focus

fashion

hotspot

Hollywood unions extend contract negotiations for actors

STAT letters to the editor on burnt

The cancer drug shortage isn’t new — and neither are the solutions

What we owe ALS patients — and why one company fell short

Drug repurposing or repositioning? The language matters

AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B

Affirmative action in medical school literally saved lives

Flu, Covid vaccination rates decline, new survey data show

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Patients' immediate access to test results puts radiologists in a bind

focus

Patients' immediate access to test results puts radiologists in a bind

The Karikó problem: Lessons for funding basic research

Health insurers' Q3 question: how much care are people getting?

The United States is paying nearly triple for new Covid vaccines

After sickle

STAT Health News: mRNA flu shots, Purdue SCOTUS case, etc

focus

focus

focus

explore